首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1578281

全球抗真菌藥物市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Antifungal Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球抗真菌藥物市場需求預計將從 2023 年的 215.2 億美元達到近 318.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 4.45%。

抗真菌藥物是指主要用於治療念珠菌病、癬、香港腳等多種感染的藥物殺菌劑。這些藥物可以透過醫生處方輕鬆購買，而有些藥物可以在櫃檯購買。真菌感染是由於生物體通過分解活組織（也稱為皮癬菌）而產生的。它們可以利用角蛋白並引起頭髮、皮膚和指甲感染。這些藥物的唯一目的是透過使細胞內容物破裂來抑制真菌細胞的生長。不衛生的環境可能會導致嚴重的皮膚感染。

市場動態

該市場的成長可歸因於透過線上廣告以及各種產品對產品可用性的認知不斷提高。除此之外，免疫性疾病發生率的增加和環境條件的變化，以及許多傳染病在個體之間傳播的增加也推動了需求。曲霉菌病和念珠菌病等真菌感染數量的增加也導致預測期內的需求激增。然而，替代品的可用性阻礙了市場的成長。同時，採用先進技術製造多種藥物並為全球多種傳染病提供有效的治療程序，將為未來幾年的市場成長開闢新的途徑。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球抗真菌藥物市場的各個細分市場進行了包容性評估。抗真菌藥物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

抗真菌藥物市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按藥物類別

唑類
棘白菌素
多烯
烯丙胺
其他

按指示

皮癬菌病
麴菌病
念珠菌病
其他

依劑型分類

口服藥物
藥膏
粉末
其他

按配銷通路

醫院藥房
零售藥房
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲抗真菌藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。抗真菌藥物市場的主要參與者包括諾華公司、輝瑞公司、拜耳公司、賽諾菲公司、默克公司、葛蘭素史克公司、雅培公司、格倫馬克公司、恩佐製藥公司、安斯泰來製藥公司。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按藥品類別分類的市場吸引力分析
- 按指標進行的市場吸引力分析
- 按劑型分類的市場吸引力分析
- 按配銷通路分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球抗真菌藥物市場分析：按藥物類別

按藥物類別概述
歷史和預測數據
按藥物類別分析
唑類
棘白菌素
多烯
烯丙胺
其他

第 6 章：全球抗黴菌藥物市場分析：依適應症分類

按指示概述
歷史和預測數據
按指標分析
皮癬菌病
麴菌病
念珠菌病
其他

第 7 章：全球抗黴菌藥物市場分析：按劑型

按劑型概述
歷史和預測數據
按劑型分析
口服藥物
藥膏
粉末
其他

第 8 章：全球抗真菌藥物市場分析：按分銷管道

配銷通路概述
歷史和預測數據
按配銷通路分析
醫院藥房
零售藥房
其他

第 9 章：全球抗黴菌藥物市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：抗真菌藥物公司的競爭格局

抗真菌藥物市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Novartis AG

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Bayer AG

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

GlaxoSmithKline Plc

公司概況
公司收入
產品
最新動態

Abbott

公司概況
公司收入
產品
最新動態

Glenmark

公司概況
公司收入
產品
最新動態

Enzon Pharmaceuticals Inc.

公司概況
公司收入
產品
最新動態

Astellas Pharma Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11214197

The global demand for Antifungal Drugs Market is presumed to reach the market size of nearly USD 31.85 Billion by 2032 from USD 21.52 Billion in 2023 with a CAGR of 4.45% under the study period 2024-2032.

Antifungal drugs refer to a pharmaceutical fungicide primarily used to treat many infections like candidiasis, ringworms, athletes' feet, and others. These drugs can easily be purchased through a doctor's prescription, whereas some are available over the counter. Fungal infections arise due to organism feed by breaking down the living tissues, also known as dermatophytes. They can utilize keratin protein and cause infection over hair, skin, and nails. The only purpose of these drugs is to inhibit the fungal cell from growing by making the cell's content break out. An unhygienic environment may drive to a severe condition in causing an infection on the skin.

MARKET DYNAMICS

The growth of this market can be attributed to rising awareness about the products' availability through online advertisement along with a wide range of products. In addition to this, increasing occurrences of immunological diseases and changing environmental conditions, and the rise in the spread of many infectious diseases from individual to individual are also boosting the demand. A rising number of fungal infections like aspergillosis and candidiasis are also upsurging the demand during the forecast period. However, the availability of substitute is hindering the market growth. At the same time, the adoption of advanced technologies in manufacturing many drugs and providing effective treatment procedures for diverse infectious diseases globally is ready to create a new avenue for market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Antifungal Drugs. The growth and trends of Antifungal Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Antifungal Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Azoles
Echinocandins
Polyenes
Allylamines
Others

By Indication

Dermatophytosis
Aspergillosis
Candidiasis
Others

By Dosage Form

Oral Drugs
Ointments
Powders
Others

By Distribution Channel

Hospital Pharmacies
Retails Pharmacies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antifungal Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antifungal Drugs market include Novartis AG, Pfizer Inc., Bayer AG, Sanofi, Merck & Co. Inc., GlaxoSmithKline Plc, Abbott, Glenmark, Enzon Pharmaceuticals Inc., Astellas Pharma Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANTIFUNGAL DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Dosage Form
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data
5.3. Analysis By Drug Class
5.4. Azoles Historic and Forecast Sales By Regions
5.5. Echinocandins Historic and Forecast Sales By Regions
5.6. Polyenes Historic and Forecast Sales By Regions
5.7. Allylamines Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data
6.3. Analysis By Indication
6.4. Dermatophytosis Historic and Forecast Sales By Regions
6.5. Aspergillosis Historic and Forecast Sales By Regions
6.6. Candidiasis Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DOSAGE FORM

7.1. Overview By Dosage Form
7.2. Historical and Forecast Data
7.3. Analysis By Dosage Form
7.4. Oral Drugs Historic and Forecast Sales By Regions
7.5. Ointments Historic and Forecast Sales By Regions
7.6. Powders Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data
8.3. Analysis By Distribution Channel
8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
8.5. Retails Pharmacies Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL ANTIFUNGAL DRUGS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANTIFUNGAL DRUGS COMPANIES

10.1. Antifungal Drugs Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF ANTIFUNGAL DRUGS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Novartis AG
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Pfizer Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Bayer AG
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Sanofi
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Merck & Co. Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. GlaxoSmithKline Plc
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Abbott
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Glenmark
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Enzon Pharmaceuticals Inc.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Astellas Pharma Inc
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments